U.S. Renewable Energy Stock News

NasdaqGS:HURC
NasdaqGS:HURCMachinery

Hurco Companies (HURC) Loss Per Share Narrows In Q2 2026 Challenging Bearish Narratives

Hurco Companies (HURC) reported Q2 2026 revenue of US$47.6 million, with a loss per share (EPS) of US$0.37 and net income excluding extra items showing a loss of US$2.4 million, setting another unprofitable quarter against a share price of US$21.13. The company has seen quarterly revenue move from US$40.9 million and a loss per share of US$0.63 in Q2 2025 to US$47.6 million and a loss per share of US$0.37 in Q2 2026. Trailing 12 month figures show revenue of US$181.8 million and a net loss...
NYSE:GNK
NYSE:GNKShipping

Genco Shipping Proxy Battle Puts Board Control And Valuation In Focus

Genco Shipping & Trading (NYSE:GNK) is in an escalating proxy contest with its largest shareholder, Diana Shipping Inc. Diana is seeking to replace Genco’s board and gain control of the company, while Genco’s directors oppose the effort. Independent proxy advisory firms Glass Lewis & Co. and Egan-Jones have publicly recommended that shareholders support Genco’s current board ahead of the June 18, 2026 annual meeting. For investors watching NYSE:GNK, this governance fight comes after a...
NYSE:AM
NYSE:AMOil and Gas

Antero Midstream Acquisition Reshapes Scale EBITDA Growth And Risk Profile

Antero Midstream (NYSE:AM) has completed its largest acquisition ahead of schedule. The company is working to integrate the acquired assets, with a focus on water system integration by year-end. Management is targeting high single digit EBITDA growth and greater financial flexibility following the transaction. Antero Midstream operates midstream infrastructure that supports energy production, including gathering, compression, and water services. For investors watching the midstream space,...
NYSE:DDS
NYSE:DDSMultiline Retail

Dillard's Restructuring Approval Raises Questions On Control And Valuation

Shareholders of Dillard's (NYSE:DDS) have approved a corporate restructuring that includes a merger with W.D. Company, Inc. The vote also supports the issuance of new Class A and Class B shares as part of the transaction. This approval clears the way for changes to Dillard's capital structure and corporate governance framework. Dillard's operates a broad network of department stores, with a focus on apparel, cosmetics, and home goods. The sector has been reshaped by e-commerce, changing...
OTCPK:NLST
OTCPK:NLSTElectronic

Assessing Netlist (OTCPK:NLST) Valuation After AI Data Center Demand And SK Hynix Contract Dependence

Why Netlist’s Growth Drivers Are Getting So Much Attention Netlist (NLST) is drawing fresh attention after rapid revenue growth tied to AI data center demand, tight memory supply, and large resale volumes from SK Hynix put its supplier and contract exposure in focus. See our latest analysis for Netlist. At a share price of $2.91, Netlist has pulled back around 7% over the past day and 5% over the past week, yet retains a 90 day share price return of about 139% and a year to date share price...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

G III Apparel Group (GIII) Margin Compression Challenges Bullish Earnings Narratives

G-III Apparel Group (GIII) opened fiscal 2027 with Q1 revenue of US$535.9 million and basic EPS of US$1.58, presenting a very different earnings profile compared with the more mixed quarters that ran through fiscal 2026. Over the last six reported periods, revenue has moved between US$535.9 million and US$988.6 million while quarterly basic EPS has ranged from a loss of US$0.76 to a profit of US$1.91, giving you a wide view of how the earnings engine has behaved across different seasons...
NasdaqGS:SHOE
NasdaqGS:SHOESpecialty Retail

Shoe Carnival (SCVL) Quarterly Loss And Margin Compression Reinforce Bearish Profitability Narratives

Shoe Carnival (SCVL) opened Q1 2027 with revenue of US$270.7 million and a loss per share of US$0.21, as net income moved to a loss of US$5.6 million for the quarter. Over the past year, the company has seen trailing twelve month revenue at about US$1.13 billion and EPS of US$1.36, compared with trailing revenue of US$1.20 billion and EPS of US$2.72 back in Q4 2025, setting a clear context for how the latest quarter fits into a longer earnings reset. For investors, the shift from quarterly...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

A Look At Kyivstar Group (NasdaqGS:KYIV) Valuation As Shares Show Recent Mixed Returns

Kyivstar Group stock reaction Kyivstar Group (KYIV) has drawn fresh attention after recent trading left the stock at US$13.73, with returns mixed, down 1.5% over the past day but up over the past month and past 3 months. See our latest analysis for Kyivstar Group. That mixed daily and weekly picture sits alongside a 30 day share price return of 8.0%, a 90 day share price return of 15.6% and a 1 year total shareholder return of 20.9%. Recent momentum therefore appears to be building from a...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Cooper Companies (COO) Margin Hit And Q2 Loss Challenge Bullish Earnings Narratives

Cooper Companies (COO) has put mixed numbers on the table for Q2 2026, with revenue at US$1.1 billion, a reported loss of US$77.9 million and basic EPS of US$0.40 loss, setting a very different tone from the prior few quarters of positive earnings. Over the past six quarters, revenue has moved from US$964.7 million in Q1 2025 to US$1.1 billion in Q2 2026. Basic EPS has ranged from US$0.52 in Q1 2025 to US$0.67 in Q1 2026 before flipping to a loss this quarter, leaving investors focused...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Lululemon Athletica (LULU) Margin Compression In Q1 2027 Challenges Bullish Growth Narratives

Lululemon Athletica (LULU) opened fiscal Q1 2027 with total revenue of US$2.5b and basic EPS of US$1.70, alongside net income of US$195.0m, setting the tone for how the new year is starting after a busy 2026. The company has seen quarterly revenue move from US$2.4b and EPS of US$2.61 in Q1 2026 to US$2.5b and EPS of US$1.70 in Q1 2027, with trailing twelve month revenue at US$11.2b and EPS at US$12.76, which gives a fuller sense of scale. For investors, the focus now is on how these results...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

A Look At Kodiak AI (KDK) Valuation After A Prolonged Share Price Decline

Short term stock performance check Kodiak AI (KDK) has been on many watchlists after a weak share performance, with the stock down about 3% over the past week and about 17% over the past month. Looking further back, the stock has declined about 23% over the past 3 months and about 40% over the past year. This provides additional context for anyone tracking shorter term shifts. See our latest analysis for Kodiak AI. With the share price at $6.88 and the 1 year total shareholder return down...
NYSE:CURV
NYSE:CURVSpecialty Retail

Torrid Holdings (CURV) Posts First Quarterly Profit As Losses Challenge Bullish Turnaround Narrative

Torrid Holdings (CURV) opened Q1 2027 with total revenue of US$245.8 million, basic EPS of roughly US$0.00, net income of US$0.4 million and same store sales that fell 1.7% year over year. Over recent quarters the company has seen revenue move from US$265.97 million in Q1 2026 to US$245.8 million in Q1 2027, while basic EPS shifted from about US$0.06 in Q1 2026 to roughly US$0.00 in the latest quarter. With the trailing twelve month line still showing a loss and revenue effectively flat, this...
OTCPK:FGPR
OTCPK:FGPRGas Utilities

Ferrellgas Partners (OTCPK:FGPR) Profit Return Challenges Bearish Earnings Narratives

Ferrellgas Partners (OTCPK:FGPR) has just posted its Q2 2026 numbers, with revenue of US$641.4 million and basic EPS of US$2.51. The trailing twelve month figures show revenue of about US$1.9 billion and basic EPS of US$1.31, as earnings have shifted from earlier losses into profit over the past year. Over recent quarters, revenue has ranged from US$343.6 million to US$669.8 million and basic EPS has swung between a loss of US$18.83 and a profit of US$2.51. This sets up a story where margins...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

CABINET Results Broaden CABOMETYX Neuroendocrine Reach And Investor Considerations

Exelixis reported new phase 3 CABINET trial data for CABOMETYX in advanced neuroendocrine tumors. The subgroup analysis showed significant improvements in progression free survival regardless of tumor functional status. These data were presented at ASCO 2026 and expand the evidence base for CABOMETYX in neuroendocrine tumors. For investors following NasdaqGS:EXEL, the CABINET subgroup results arrive with the stock at $52.7 and strong recent returns, including 20.9% year to date and 22.5%...
NYSE:RCUS
NYSE:RCUSBiotechs

A Look At Arcus Biosciences (RCUS) Valuation After Recent Share Price Weakness

Recent stock performance and business context Arcus Biosciences (RCUS) has drawn attention after recent share price moves, with the stock down 6.1% on the day and about 10.8% over the past month, while still up over the past 3 months. At a recent close of US$23.19 and a market value of around US$3.1b, the company remains a clinical stage cancer therapy developer with revenue of US$236.0m and a reported net loss of US$369.0m. See our latest analysis for Arcus Biosciences. Recent moves have...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Do Sharplink’s (SBET) Upgraded Earnings Estimates Reveal a Turning Point in Its Investment Narrative?

Recently, Zacks Investment Research upgraded Sharplink Inc. (SBET) to a Rank #2 (Buy), citing an upward trend in the company’s earnings estimates. This reassessment of Sharplink’s earnings outlook highlights how revisions in expectations can influence investor perception of the business’s longer-term potential. Next, we’ll explore how this improved earnings outlook, reflected in the Zacks upgrade, shapes Sharplink’s broader investment narrative. Invest in the nuclear renaissance through our...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Regulators Weigh Paramount Skydance Deal As WBD Streaming Turns Profitable

Paramount Skydance's acquisition of Warner Bros. Discovery (NasdaqGS:WBD) is moving through global regulatory reviews, including a formal process in Europe. U.S. attorneys general are examining potential competition and industry impacts from the proposed Hollywood combination. Warner Bros. Discovery has reported a profitable streaming segment and recorded a substantial, one off merger related fee that resulted in a large loss. Warner Bros. Discovery, the media and entertainment group behind...
NYSE:NVR
NYSE:NVRConsumer Durables

Is It Time To Reassess NVR (NVR) After Recent Share Price Weakness?

Wondering whether NVR at around US$6,182 per share is offering fair value or an opportunity? This article looks at what the current price really reflects. The stock has edged up 1.3% over the past week and 1.4% over the past month, yet is still down 15.1% year to date and 13.1% over the last year. This naturally raises questions about how the market is assessing its prospects and risks. Recent attention on NVR has focused on its broader sector context and housing market conditions, with...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

PENN Entertainment Bets On New Aurora Casino And Valuation Gap

PENN Entertainment (NasdaqGS:PENN) is opening the new US$360 million Hollywood Casino Aurora as its latest land-based flagship in Illinois. The long-running Hollywood Casino riverboat in Aurora is set to close after more than 30 years of operation as activity shifts to the new property. The new complex combines gaming, hotel rooms, dining, and entertainment offerings in a single, purpose-built facility. The move reflects PENN Entertainment's push to grow its brick and mortar footprint...
NYSE:AB
NYSE:ABCapital Markets

Is AllianceBernstein Holding (AB) Fairly Priced After Recent Share Price Weakness

If you are wondering whether AllianceBernstein Holding at around US$37.19 is attractively priced or asking too much for future returns, the starting point is understanding what the current valuation is actually baking in. The stock has been relatively steady over the past week with a 0.5% gain, while it has fallen 7.8% over the last month, is down 3.8% year to date, yet still shows a 2.4% return over one year, 39.4% over three years and 24.1% over five years. Recent coverage has focused on...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

Does First Financial Bankshares (FFIN) Justify Its Premium P/E After Mixed Share Price Performance?

Wondering if First Financial Bankshares at around US$32.35 is offering value or asking too much of your capital? This article focuses squarely on what the current share price might imply about the stock. The share price is up 7.8% year to date, even though the stock has fallen 1.1% over the last week and 7.0% over the past year, with a 29.9% decline across five years and a 17.2% gain across three years adding more mixed signals. Recent coverage has focused on the bank's positioning in its...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch + Lomb’s New Dry Eye Launch And What It Means For BLCO

Bausch + Lomb (NYSE:BLCO) has launched Blink Triple Care Preservative Free eye drops in the U.S. The product is a preservative free, long lasting dry eye treatment available in a multi dose bottle. The launch expands the Blink brand within the competitive U.S. dry eye market. Bausch + Lomb, a long standing player in eye health, is adding Blink Triple Care Preservative Free to its U.S. product portfolio at a time when dry eye treatments are drawing more consumer attention. Patients and eye...
OTCPK:TYCB
OTCPK:TYCBBanks

Calvin B. Taylor Bankshares Q1 Net Margin Strength Reinforces Steady Community Bank Narrative

Calvin B. Taylor Bankshares (TYCB) kicked off Q1 2026 with total revenue of US$9.7 million and net income of US$3.8 million, translating into basic EPS of US$1.44, compared with Q1 2025 levels of US$9.6 million in revenue and US$3.7 million of net income, or EPS of US$1.36. Over the last twelve months, revenue has moved from US$35.7 million to US$39.2 million, while net income has gone from US$13.8 million to US$15.5 million and EPS has stepped up from US$5.05 to US$5.74. This gives investors...
NYSE:FLR
NYSE:FLRConstruction

Fluor’s US$1.03b Naval Nuclear Deal And What It Means For Valuation

Fluor (NYSE:FLR) received a US$1.03b contract modification from the U.S. Naval Sea Systems Command. The award supports the Naval Nuclear Laboratory and expands Fluor’s role in a major naval nuclear propulsion program. The contract modification is structured as a multi-year assignment focused on critical government work. For investors watching NYSE:FLR, this contract modification adds a large, long-duration project in U.S. defense alongside the company’s existing LNG and infrastructure work...